| | |
Asthma
|
Allergic rhinitis
|
Eczema
|
|---|
| |
Number
|
Crude prevalence (%)(95% CI )
|
Adjusted prevalence (%)(95% CI )
|
Crude prevalence (%)(95% CI )
|
Adjusted prevalence (%)(95% CI )
|
Crude prevalence (%)(95% CI )
|
Adjusted prevalence (%)(95% CI )
|
|---|
|
Total
|
22,009
|
3∙3 (3∙1-3∙6)
|
3∙3 (3∙1-3∙6)
|
9∙8 (9∙4-10∙2)
|
9∙8 (9∙4-10∙2)
|
5∙5 (5∙2-5∙8)
|
5∙5 (5∙2-5∙8)
|
|
Harbin(4)
|
2,900
|
1∙4 (1∙0-1∙9)
|
1∙7 (1∙0-2∙4)
|
4∙9 (4∙1-5∙7)
|
4∙9 (3∙9-5∙8)
|
5∙3 (4∙5-6∙1)
|
4∙7 (3∙9-5∙5)
|
|
Shanghai(10)
|
4,395
|
7∙2 (6∙4-8∙0)
|
7∙0 (6∙0-7∙9)
|
12∙9 (11∙9-13∙9)
|
13∙1 (11∙7-14∙5)
|
6∙4 (5∙7-7∙1)
|
6∙5 (5∙4-7∙5)
|
|
Guangzhou(4)
|
3,094
|
3∙0 (2∙4-3∙6)
|
3∙0 (2∙4-3∙6)
|
16∙7 (15∙4-18∙0)
|
16∙8 (15∙3-18∙2)
|
5∙3 (4∙5-6∙1)
|
5∙4 (4∙6-6∙2)
|
|
Xi'an(3)
|
1,653
|
1∙1 (0∙6-1∙6)
|
1∙1 (0∙6-1∙7)
|
3∙9 (3∙0-4∙8)
|
3∙9 (2∙9-4∙9)
|
4∙4 (3∙4-5∙4)
|
4∙4 (3∙4-5∙4)
|
|
Wuhan(4)
|
2,061
|
3∙6 (2∙8-4∙4)
|
3∙5 (2∙7-4∙3)
|
8∙5 (7∙3-9∙7)
|
8∙3 (7∙1-9∙6)
|
6∙0 (5∙0-7∙0)
|
6∙1 (5∙0-7∙2)
|
|
Chengdu(5)
|
2,848
|
4∙5 (3∙8-5∙3)
|
4∙6 (3∙8-5∙4)
|
9∙9 (8∙8-11∙0)
|
10∙1 (8∙9-11∙2)
|
4∙2 (3∙5-4∙9)
|
4∙3 (3∙5-5∙1)
|
|
Hohhot(5)
|
2,025
|
1∙0 (0∙6-1∙5)
|
0∙9 (0∙5-1∙4)
|
5∙4 (4∙4-6∙4)
|
4∙5 (3∙6-5∙4)
|
6∙2 (5∙2-7∙2)
|
6∙4 (4∙9-7∙9)
|
|
Urumqi(4)
|
2,033
|
1∙5 (1∙0-2∙1)
|
1∙6 (1∙0-2∙1)
|
10∙3 (9∙0-11∙6)
|
10∙1 (8∙6-11∙5)
|
5∙9 (4∙9-6∙9)
|
5∙9 (4∙8-6∙9)
|
|
**P
| |
<0∙001
|
<0∙001
|
<0∙001
|
<0∙001
|
<0∙001
|
<0∙001
|
- Numbers of centers is indicated in brackets next to city name.*Adjusted to the age and gender distribution of the total sample. **P-value for difference between sites.
